메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Purpose There is no regimen that is strongly recommended for more than second-line treatment. We investigated the efficacy and safety of platinum/vinorelbine as more than second-linetreatment. Materials and MethodsWe selected patients with advanced non-small cell lung cancer (NSCLC) who received treatmentwith platinum/vinorelbine at Chungnam National University Hospital from August2001 to December 2013. The primary end point was the response rate, and secondary endpoints were progression-free survival (PFS), overall survival (OS), and toxicity. ResultsThirty-five patients were enrolled. Response rate was 22.9% (complete response, 0 patients[0%]; partial response, eight patients [22.9%]; stable disease, 10 patients [28.6%]; progressivedisease, 14 patients [40.0%]). A significantly higher response rate was observed forpatients who had responded to previous chemotherapy than for those who did not (34.8%[8/23] vs. 0% [0/12], p=0.020). The median PFS was 4 months (range, 1 to 21 months). Patients with adenocarcinoma and non-smokers had a significantly longer PFS than patientswith non-adenocarcinoma and smokers (5 months vs. 2 months, p=0.007; 4.5 months vs. 2 months, p=0.046, respectively). The median OS was 10 months (range, 1 to 41 months). Patients with good performance status and non-smokers had a significantly longer OS thanpatients with poor performance status and smokers (14 months vs. 4 months, p=0.02;18.5 months vs. 6 months, p=0.049, respectively). The main serious adverse event (grade3 or 4) was neutropenia (15 events, 13.3%) in a total of 113 cycles. ConclusionPlatinum/vinorelbine was effective as more than second-line chemotherapy, and the toxicitywas tolerable, in patients with advanced NSCLC.

목차

등록된 정보가 없습니다.

참고문헌 (16)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0